Publications en collaboration avec des chercheurs de Hospital Vall d'Hebron (39)

2024

  1. ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility

    Molecular Oncology

  2. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness

    Journal of Parkinson's disease, Vol. 13, Núm. 2, pp. 219-231

  3. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

  4. Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group

    Parkinson's Disease, Vol. 2023

  5. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  6. STAT-ON™: The holter for parkinson's disease motor symptoms. Real use cases in clinical praxis

    A Holter for Parkinson's Disease Motor Symptoms: STAT-ON™ (River Publishers), pp. 151-206

2022

  1. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group

    Journal of Parkinson's Disease, Vol. 12, Núm. 1, pp. 315-331

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

    Journal of Parkinson's Disease, Vol. 12, Núm. 3, pp. 935-955

  4. Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients

    International Journal of Geriatric Psychiatry, Vol. 37, Núm. 6

2021

  1. Epigenome-wide association study of COVID-19 severity with respiratory failure

    EBioMedicine, Vol. 66

  2. Morphological Description of Frontal EEG Interictal and Ictal Discharges in an Adult Cohort of 175 Patients

    Journal of Clinical Medicine, Vol. 10, Núm. 6, pp. 1219

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  3. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Cell Reports Medicine, Vol. 1, Núm. 8

2019

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

    European Journal of Neurology, Vol. 26, Núm. 11, pp. 1399-1407

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

2013

  1. Desenvolvimento e validação de um método de imunonefelometria em amostras de sangue em papel-filtro para a dosagem da alfa-1 antitripsina em pacientes com DPOC

    Jornal Brasileiro de Pneumologia, Vol. 39, Núm. 5, pp. 547-554